Literature DB >> 28214423

Distinct metastatic patterns in colorectal cancer patients based on primary tumour location.

Niek Hugen1, Iris D Nagtegaal2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28214423     DOI： 10.1016/j.ejca.2017.01.003

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  9 in total

1.  Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.

Authors:  Rona Yaeger; Walid K Chatila; Marla D Lipsyc; Jaclyn F Hechtman; Andrea Cercek; Francisco Sanchez-Vega; Gowtham Jayakumaran; Sumit Middha; Ahmet Zehir; Mark T A Donoghue; Daoqi You; Agnes Viale; Nancy Kemeny; Neil H Segal; Zsofia K Stadler; Anna M Varghese; Ritika Kundra; Jianjiong Gao; Aijazuddin Syed; David M Hyman; Efsevia Vakiani; Neal Rosen; Barry S Taylor; Marc Ladanyi; Michael F Berger; David B Solit; Jinru Shia; Leonard Saltz; Nikolaus Schultz
Journal:  Cancer Cell       Date:  2018-01-08       Impact factor: 31.743

2.  Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study.

Authors:  C Zheng; F Jiang; H Lin; S Li
Journal:  Clin Transl Oncol       Date:  2019-03-14       Impact factor: 3.405

3.  The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival.

Authors:  Nelleke P M Brouwer; Dave E W van der Kruijssen; Niek Hugen; Ignace H J T de Hingh; Iris D Nagtegaal; Rob H A Verhoeven; Miriam Koopman; Johannes H W de Wilt
Journal:  Ann Surg Oncol       Date:  2019-12-02       Impact factor: 5.344

Review 4.  Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance.

Authors:  Anne E Tuomisto; Markus J Mäkinen; Juha P Väyrynen
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

5.  Assessment of a Size-Based Method for Enriching Circulating Tumour Cells in Colorectal Cancer.

Authors:  Sai Shyam Vasantharajan; Edward Barnett; Elin S Gray; John L McCall; Euan J Rodger; Michael R Eccles; Fran Munro; Sharon Pattison; Aniruddha Chatterjee
Journal:  Cancers (Basel)       Date:  2022-07-15       Impact factor: 6.575

Review 6.  Mutations and mechanisms of WNT pathway tumour suppressors in cancer.

Authors:  Jeroen M Bugter; Nicola Fenderico; Madelon M Maurice
Journal:  Nat Rev Cancer       Date:  2020-10-23       Impact factor: 60.716

7.  Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases.

Authors:  Hong-Wei Wang; Xiao-Luan Yan; Li-Jun Wang; Meng-Huan Zhang; Chun-He Yang; Ke-Min Jin; Quan Bao; Juan Li; Kun Wang; Bao-Cai Xing
Journal:  J Transl Med       Date:  2021-07-19       Impact factor: 5.531

8.  Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer.

Authors:  Vincenzo Formica; Maria Teresa Ionta; Bruno Massidda; Giacomo Vessia; Luigi Maiorino; Rossana Casaretti; Donato Natale; Giuseppe Barberis; Gianfranco Filippelli; Ettore Greco; Livio Blasi; Sergio Mancarella; Anna Russo; Enrico Barbato; Liberato Di Lullo; Mario Roselli
Journal:  Oncotarget       Date:  2017-12-17

9.  Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis.

Authors:  Joshua D G Leach; Nikola Vlahov; Petros Tsantoulis; Rachel A Ridgway; Dustin J Flanagan; Kathryn Gilroy; Nathalie Sphyris; Ester G Vázquez; David F Vincent; William J Faller; Michael C Hodder; Alexander Raven; Sigrid Fey; Arafath K Najumudeen; Douglas Strathdee; Colin Nixon; Mark Hughes; William Clark; Robin Shaw; Sander R van Hooff; David J Huels; Jan Paul Medema; Simon T Barry; Margaret C Frame; Asier Unciti-Broceta; Simon J Leedham; Gareth J Inman; Rene Jackstadt; Barry J Thompson; Andrew D Campbell; Sabine Tejpar; Owen J Sansom
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.